Navigation Links
Cepheid Reports Second Quarter Revenue of $42.1 Million
Date:7/24/2008

and non-GAAP gross margin

on product sales was 43%, which compares to 41% and 42% in the second

quarter of fiscal 2007.

-- Cash, cash equivalents and investments increased to $46.8 million as

of June 30, 2008.

-- DSOs improved to 40 days.

Business Outlook

For the fiscal year ending December 31, 2008, the Company expects:

-- Total revenue to be in the range of $173 to $177 million, of which

product sales are expected to be in the range of $164 to $167 million.

o Xpert MRSA test sales are expected to be in the range of $52 to

$55 million.

-- Net loss for 2008 is expected to be in the range of $20 to $22

million, or $(0.35) to $(0.38) per share.

-- On a non-GAAP basis, net loss is expected to be in the range of $4 to

$6 million, or $(0.07) to $(0.10) per share.

-- Non-GAAP net loss excludes approximately $15 million related to stock

compensation expense and $1 million related to the amortization of

acquired intangibles.

Accessing Cepheid's Q208 Earnings Conference Call

The company will host a management presentation at 1:30 p.m. Pacific Time on Thursday, July 24, 2008 to discuss the results. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants and investors may also listen to the live teleconference call by dialing 866-825-1692 (domestic) or 617-213-8059 (international), and entering participant code 92219619. A replay will be available for seven days beginning at 3:30 p.m. Pacific Time. Access numbers for this replay are 888-286-8010 (domestic) an
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... reviews and editorials addressing developments and pathways related ... a provocative article exploring the role of follicle-stimulating ... treatment of prostate cancer. , The article ... possibility that there could be a connection to ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... developing new sensors to detect chemical agents and illegal drugs ... terrorist attacks. The devices will use special gel pads ... sample which is then analysed by a scanning instrument that ... allow better, faster decisions to be made in response to ...
... , , NEW YORK, ... research report is available in its catalogue: , ... http://www.reportlinker.com/p0170008/Infectious-Disease-Molecular-Diagnostic-Testing.html , The report ... needs for major infectious diseases, as well as extensive ...
... , , , , ... novel stem cell based,technology of Cellonis Biotechnologies, Beijing, a Chinese ... a 36 year old Norwegian,patient in a hospital in Beijing. ... tumor stem cells as well as cancer daughter,cells. The amazing ...
Cached Biology Technology:New technology detects chemical weapons in seconds 2Reportlinker Adds Infectious Disease Molecular Diagnostic Testing 2For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 2For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 3For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing 4
(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... discovered the world,s deepest undersea volcanic vents, known as ... Cayman Trough in the Caribbean. Using a deep-diving ... Cook, the scientists found slender spires made of copper ... enough to melt lead, nearly half a mile deeper ...
... Mass. Using a sensor that weighs cells with unprecedented ... which single cells accumulate mass a feat that could ... those controls fail in cancer cells. The research team, ... revealed that individual cells vary greatly in their growth rates, ...
... (BRONX, NY) In a step towards a possible ... of Medicine of Yeshiva University have shown for the ... may explain damaging cellular behavior in Huntington,s disease. Their ... of Nature Neuroscience . Huntington,s disease, which ...
Cached Biology News:British scientific expedition discovers world's deepest known undersea volcanic vents 2British scientific expedition discovers world's deepest known undersea volcanic vents 3MIT: New cell measurement system 2Faulty clean-up process may be key event in Huntington's disease 2
... anti-freeze environment for enzyme conjugated antibodies and ... viscosity solution at -20C , No ... is convenient , Contains preservatives to ... Protect enzyme conjugates during storage without the ...
Request Info...
... Tecans GenePaint system, which is based on ... steps required for performing in situ hybridization of ... key step in the study of gene expression, ... cells and tissues and can be used to ...
... The Microarray Gene Frame® has ... hybridisations. These frames feature the same ... standard Gene Frame® range for easy ... hybridisation uniformity and there are three ...
Biology Products: